Pelvic Ultra-Hypofractionated Adjuvant Radiotherapy for Endometrial Cancer (PURE-cohort)
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Endometrial Cancer
Related studies linked through entity extraction aliases.
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
- Status
- RECRUITING
- Phase
- PHASE1
A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Advancing Risk Stratification in Endometrial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Development Of An Endometrial Cancer Educational Tool
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Evaluating the Addition of OK-1 Weekly Paclitaxel in Patients With Endometrial Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Comparison of Lee-Huang Point and Umbilical Entry for Laparoscopic Success in Endometrial Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Low-Residue Diet Versus Rectal Enema Before Laparoscopic Surgery for Endometrial Cancer
- Status
- RECRUITING
- Phase
- NA
Intraoperative Microscopic Assessment of Lymph Node Status in Gynecological Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
DETERMINANTS OF IMMUNOTHERAPY EFFICACY IN ENDOMETRIAL CANCER
- Status
- RECRUITING
- Phase
- NA
ctDNA Assessment in Endometrial Cancer for Adjuvant Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Phase 1 Study to Evaluate the Safety and Efficacy of OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer
- Status
- RECRUITING
- Phase
- NA
68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Fasting InTervention for Endometrial Cancer
- Status
- RECRUITING
- Phase
- NA
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Tirzepatide in the Treatment of Endometrial Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2